Literature DB >> 19151253

Role of angiotensin II and oxidative stress in vascular insulin resistance linked to hypertension.

Ming-Sheng Zhou1, Ivonne Hernandez Schulman, Leopoldo Raij.   

Abstract

Insulin activation of the phosphatidylinositol 3-kinase (PI3K) pathway stimulates glucose uptake in peripheral tissues and synthesis of nitric oxide (NO) in the endothelium. Insulin resistance (IR) and hypertension frequently coexist, particularly among individuals with salt-sensitive hypertension. The mechanisms underlying this association are poorly understood. We investigated these mechanisms in a model of salt-sensitive hypertension in which we have previously shown that endothelial dysfunction is mediated by superoxide anion (O(2)(-)) linked to local ANG II. Dahl salt-sensitive rats were fed, for 6 wk, a normal salt diet (NS; 0.5% NaCl), high-salt diet (HS; 4% NaCl), HS plus the ANG II type 1 receptor (AT(1)R) blocker (ARB) candesartan (10 mg.kg(-1).day(-1)), or HS plus the antioxidant tempol (172 mg/l in drinking water). Hypertensive (mean arterial pressure: 145 +/- 4 vs. 102 +/- 5 mmHg in NS, P < 0.05) rats manifested increased aortic AT(1)R mRNA (210%) and protein (101%) expression and O(2)(-) production (104%) and impaired endothelium-dependent relaxation (EDR) to acetylcholine [maximal response (E(max)): 68 +/- 9 vs. 91 +/- 8% in NS, P < 0.05]. ARB or tempol normalized O(2)(-) and EDR despite that they did not normalize mean arterial pressure, which was reduced only 25%. Hypertensive rats manifested metabolic IR (36% reduction in the glucose infusion rate by insulin clamp), impaired NO-mediated insulin-induced EDR (E(max): 12 +/- 5 vs. 32 +/- 4% in NS, P < 0.05), and impaired insulin activation of PI3K/endothelial NO synthase. ARB or tempol improved insulin-mediated EDR, PI3K, Akt/ endothelial NO synthase phosphorylation, and metabolic IR (all P < 0.05). This study provides insight into the mechanisms that underlie the association between metabolic and hypertensive cardiovascular diseases and support the notion that O(2)(-) overproduction linked to tissue ANG II interferes with shared insulin signaling pathways in metabolic and cardiovascular tissues.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19151253     DOI: 10.1152/ajpheart.01096.2008

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  21 in total

1.  Acute, local infusion of angiotensin II impairs microvascular and metabolic insulin sensitivity in skeletal muscle.

Authors:  Dino Premilovac; Emily Attrill; Stephen Rattigan; Stephen M Richards; Jeonga Kim; Michelle A Keske
Journal:  Cardiovasc Res       Date:  2019-03-01       Impact factor: 10.787

2.  Effects of losartan on whole body, skeletal muscle and vascular insulin responses in obesity/insulin resistance without hypertension.

Authors:  A A Lteif; R L Chisholm; K Gilbert; R V Considine; K J Mather
Journal:  Diabetes Obes Metab       Date:  2011-11-24       Impact factor: 6.577

Review 3.  Microvascular dysfunction: an emerging pathway in the pathogenesis of obesity-related insulin resistance.

Authors:  Dennis M J Muris; Alfons J H M Houben; Miranda T Schram; Coen D A Stehouwer
Journal:  Rev Endocr Metab Disord       Date:  2013-03       Impact factor: 6.514

Review 4.  Metabolic actions of angiotensin II and insulin: a microvascular endothelial balancing act.

Authors:  Ranganath Muniyappa; Sahzene Yavuz
Journal:  Mol Cell Endocrinol       Date:  2012-06-07       Impact factor: 4.102

Review 5.  Cardiometabolic crosstalk in obesity-associated arterial hypertension.

Authors:  Jens Jordan; Andreas L Birkenfeld
Journal:  Rev Endocr Metab Disord       Date:  2016-03       Impact factor: 6.514

Review 6.  Effects of tempol and redox-cycling nitroxides in models of oxidative stress.

Authors:  Christopher S Wilcox
Journal:  Pharmacol Ther       Date:  2010-02-11       Impact factor: 12.310

7.  Angiotensin receptor-mediated oxidative stress is associated with impaired cardiac redox signaling and mitochondrial function in insulin-resistant rats.

Authors:  José Pablo Vázquez-Medina; Irina Popovich; Max A Thorwald; Jose A Viscarra; Ruben Rodriguez; Jose G Sonanez-Organis; Lisa Lam; Janos Peti-Peterdi; Daisuke Nakano; Akira Nishiyama; Rudy M Ortiz
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-06-14       Impact factor: 4.733

8.  A vascular mechanism for high-sodium-induced insulin resistance in rats.

Authors:  Dino Premilovac; Stephen M Richards; Stephen Rattigan; Michelle A Keske
Journal:  Diabetologia       Date:  2014-09-12       Impact factor: 10.122

9.  Obesity is the major contributor to vascular dysfunction and inflammation in high-fat diet hypertensive rats.

Authors:  Ahmed A Elmarakby; John D Imig
Journal:  Clin Sci (Lond)       Date:  2010-02       Impact factor: 6.124

10.  Perivascular Fat and the Microcirculation: Relevance to Insulin Resistance, Diabetes, and Cardiovascular Disease.

Authors:  A J Houben; E C Eringa; A M Jonk; E H Serne; Y M Smulders; C D Stehouwer
Journal:  Curr Cardiovasc Risk Rep       Date:  2011-11-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.